# AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19

> **NCT04649775** · NA · TERMINATED · sponsor: **Duke University** · enrollment: 11 (actual)

## Conditions studied

- Corona Virus Infection
- Respiratory Rate
- Hypoxia
- Covid19

## Interventions

- **DEVICE:** AirFLO2

## Key facts

- **NCT ID:** NCT04649775
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-04-09
- **Primary completion:** 2021-11-08
- **Final completion:** 2021-11-08
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** no eligible participants
- **Last updated:** 2022-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04649775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04649775, "AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04649775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*